system degrades a number of important cellular proteins such as oncogene products, cyclins, and transcriptional factors. The target proteins are conjugated to polypeptide ubiquitin, and then degraded by a proteasome in an ATP dependent manner1^The catalytic core of the proteasome is the 20S proteasome. New20S proteasome inhibitors would contribute to further understanding of the system2~4\ In the course of our screening program, wehave isolated several classes of 20S proteasome inhibitors including (i) the novel cyclic peptides, TMC-95s, and (ii) the new members of a',/3'-epoxyketone containing peptides, TMC-86s and TMC-96, from microbial metabolites5~s\ Our recent search resulted in the isolation of TMC-89Aand B, new members of the a',/3'-epoxyketone containing peptides, from a microbial metabolite. We describe here the taxonomy of producing strain, production, isolation, structural studies, Each spore chain, which was in the form of curves, hooks, or loops, had 5 to 30 or more spores per chain. The spores were oval to ellipsoidal, with size of0.7-0.9X 1.5-1.8 /im, and the surface was smooth. Fragmentation of substrate mycelia, sporangia, or motile spores were not observed.
The physiological properties and the utilization of carbon sources are summarized in Table 2 . Analysis of the wholecell hydrolysates showed the presence of LL-diaminopimelic acid, indicating that the cell wall belongs to type I. On the basis of these morphological and chemotaxonomic characteristics, the strain TC 1087 was assigned to the genus Streptomyces. The broth filtrate (27 liters) was applied to a Diaion HP-20 column and eluted with 50%aqueous methanol. The eluate was concentrated and subjected to a mediumpressure reverse-phase silica gel column chromatography SEPT. 2000 (MPLC, YMC ODS A60), followed by elution with 10% aqueous acetonitrile. The active eluate was concentrated and rechromatographed on a silica gel MPLC(Wako gel C300) developed with CH2C12-MeOH (7: 1) to afford semi-pure TMC-89s (560mg).
The semi-pure TMC-89s were purified by preparative HPLC (column: YMC D-ODS-5B (30mmX250mm), mobile phase: acetonitrilewater (12: 88), flow rate: 25ml/minute, detection: UV Table 3 . The molecular formula of TMC-89A and B was determined as C21H36N4O9on the basis of their HR-FAB-MS and lU and 13C NMRspectral data.
Their IR spectra exhibited the presence of hydroxyl (3300cm"1), ketone or ester (1720cm"1), and amide (1640 969 and 1530cm"1) groups. The NMRspectral data of TMC-89A and B are summarized in Table 4 . The structure of TMC-89Awas determined by the analyses of the NMR experiments such as^H COSY, NOESY, HMQCand HMBC, and MS spectrum (Fig. 1) , along with the degradation studies. The HMBCcorrelations from C-l'" (8 170.1) to 4"' -H (<5 1.17); C-3' " (<5 172.2) to.4' "-H and 3' "-NH2 (8 7.03, 7.36) , and the NOEs observed between 2"'-H (8 3.27 ) and 3"'-NH2; 2"'-H and 2"-NH (8 7.91) demonstrated the structure of C-l"' to 3"'-NH2, which was attached to 2"-NH. The remaining sequence of TMC-89A was confirmed by EI-MS spectrum as shown in Fig. 1 . The NMRdata of TMC-89Bwas almost identical to that of TMC-89A except for the slight shifts of C-l"'~C-3'" signals (Table 4) . No difference, however, was observed in the MSdata of them. Therefore, TMC-89Bwas considered to be a stereoisomer of TMC-89A. Acid hydrolysis of TMC-89Aand B with 6n HC1 gave one spot ofL-threonine as analyzed by chiral TLC. Thus, the stereochemistries of C-2', C-3', C-2", and C-3" were assigned to S, R, S, and R, respectively (Fig.  2) . In order to confirm the stereochemistry of C-2'" of TMC-89A and B, the carboxamide group (C-3'"-NH2) was reduced to an amine group by [bis(trifluoroacetoxy)iodo]benzene9l Acid hydrolysis of each reduced product of TMC-89Aand B gave L-alanine and D-alanine, respectively, along with L-threonine by the chiral TLC analyses. Thus, the configurations of C-2'" of TMC-89A and B were determined to be R and S, respectively (Fig. 2) . 20Sproteasome has three catalytic subunits and shows at Table 5 . TMC-89Aand B inhibited the T-L activity much stronger than TMC-86sand TMC-96,while all these compounds inhibited the ChT-L and PGPHactivities to a similar extent. The same inhibitory activities of TMC-89Aas TMC-89B indicated that the stereochemistry of C-2'" was not vital to their activities. TMC-89Aand B did not inhibit m-calpain, cathepsin L, and trypsin at 100 jam, suggesting their high specificity for 20S proteasome. TMC-89A and B did not show remarkable cytotoxicities to various tumor cell lines (Table 6 ).
Experimental
EnzymeAssays 20S proteasome was isolated from THP.l monocytic cells5). Other enzymes were purchased from commercial sources. The activities of enzymes were measured by using fluorescence substrates according to the method reported previously5).
Cytotoxic Assays
Cells were incubated with a test sample at 37°C for 72 hours in culture medium,and their viability was determined by the tetrazolium or neutral red assay method5).
Reduction of the Carboxamide Group TMC-89A (4.2mg) was dissolved in 0.5ml of CH3CN-H2O (1 : 1). A solution of [bis(trifluoroacetoxy)iodo]benzene (9mg in 0.1 ml CH3CN)was added, and the mixture was stirred for 6 hours under N2 atmosphere. The solvent (CH3CN) was evaporated in vacuo. The resultant liquid was acidified with 6n HC1, and washed with ether (1 ml). The water layer was concentrated to dryness and hydrolyzed with 0.2ml of6n HC1 in a sealed tube (110°C, 16 hours). The hydrolysate was analyzed by chiral TLC (HPTLC-CHIR, Merck) with a solvent of MeOH-H2O-CH3CN 
